US STOCK
JAZZ Stock Analysis
US stocks · market data · technical indicators
Jazz Pharmaceuticals plc Common Stock (Ireland)
JAZZUS stocksQuote delayed 15 min
10/27 下午12:54 updated
$205.70
-8.30-3.88%
Open
$215.29
High
$216.43
Low
$205.00
Volume
97.02萬
JAZZ price history
-13.67%Open
238.28
Latest
205.70
High
238.28
Low
205.70
Average
220.97
Advertisement
Financial snapshot
JAZZ - Jazz Pharmaceuticals plc
EPS
14.59USD
Forward EPS
25.94USD
P/E
14.10x
Forward P/E
7.93x
P/B
2.78x
ROE
22.11%
ROA
6.86%
Operating margin
26.91%
Profit margin
20.45%
Revenue growth
15.50%
Earnings growth
--
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $1.21B | $1.07B | $1.20B | $1.13B | $1.05B |
| Gross profit | $1.09B | $934.80M | $1.04B | $997.23M | $929.40M |
| Operating income | $325.20M | $336.60M | $254.53M | $100.01M | $219.00M |
| Net income | $192.80M | $293.10M | $203.45M | $251.41M | -$718.50M |
| Basic EPS | 3.05 | 4.73 | 3.33 | 4.14 | -11.74 |
| Diluted EPS | 2.78 | 4.43 | 3.21 | 4.08 | -11.74 |
Estimates vs actuals
Next earnings
2026-11-02
EPS estimate
1.97
Revenue estimate
$1.21B
Last surprise
-7.54%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-02 | 1.97 | Not reported | — |
| 2026-08-03 | 6.18 | 5.71 | -7.54% |
| 2026-05-05 | 4.66 | 6.34 | +36.18% |
| 2026-02-24 | 6.51 | 6.64 | +2.05% |
| 2025-11-05 | 5.85 | 8.13 | +38.97% |
| 2025-08-05 | -6.25 | -8.25 | -32.07% |
| 2025-05-06 | 4.66 | 1.68 | -63.93% |
| 2025-02-25 | 5.81 | 6.60 | +13.58% |
| 2024-11-06 | 5.50 | 6.61 | +20.16% |
| 2024-07-31 | 4.78 | 5.30 | +10.80% |
| 2024-05-01 | 4.18 | 2.68 | -35.90% |
| 2024-02-28 | 5.18 | 5.02 | -3.16% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $1B | 0.01% |
| BlackRock Inc. | 2024-06-30 | $655.9M | 0.01% |
| STATE STREET CORP | 2026-06-30 | $481.9M | 0.01% |
| CITADEL ADVISORS LLC | 2026-06-30 | $242.6M | 0.03% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $135.4M | 0.19% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $96.4M | 0.07% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$294.27
Target range
$225.00 – $337.00
Implied upside
43.06%
Strong buy
7
Buy
13
Hold
2
Sell
0
Strong sell
0
Advertisement